Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03266692 · TERMINATED
Trial details
- NCT number
- NCT03266692
- Sponsor
- Cogent Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-22
- Primary completion
- 2019-10-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.